➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Mallinckrodt
Dow
Moodys
Harvard Business School

Last Updated: October 26, 2020

DrugPatentWatch Database Preview

TIMENTIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for TIMENTIN
Drug patent expirations by year for TIMENTIN
Recent Clinical Trials for TIMENTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Osprey Medical, IncPhase 2

See all TIMENTIN clinical trials

US Patents and Regulatory Information for TIMENTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline TIMENTIN clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 050590-003 Aug 18, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TIMENTIN clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 050590-002 Apr 1, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TIMENTIN clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 062691-001 Dec 19, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TIMENTIN clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 050590-001 Apr 1, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline TIMENTIN IN PLASTIC CONTAINER clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 050658-001 Dec 15, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Medtronic
Express Scripts
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.